CMV-MVA Triplex

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Cytomegalovirus InfectionsHIV InfectionsLiver TransplantVaccine

Phase 2

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

CompletedNCT05099965

National Institute of Allergy and Infectious Diseases (NIAID)Cytomegalovirus Infections, HIV Infections, Vaccine

Start: 2021-11-02End: 2025-10-08Updated: 2026-05-14

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

RecruitingNCT06075745

National Institute of Allergy and Infectious Diseases (NIAID)Liver Transplant

Start: 2024-03-05End: 2028-02-28Target: 416Updated: 2026-09-16